Hualan Biological Engineering Inc
SZSE:002007
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hualan Biological Engineering Inc
SZSE:002007
|
CN |
|
E
|
ECC Ventures 6 Corp
XTSX:ECCS.P
|
CA |
|
Curtiss-Wright Corp
NYSE:CW
|
US |
|
V
|
Vixtel Technologies Holdings Ltd
HKEX:1782
|
CN |
|
Telecom Egypt Co SAE
LSE:TEEG
|
EG |
|
Jiangsu Jingxue Insulation Technology Co Ltd
SZSE:301010
|
CN |
|
ARE Holdings Inc
F:A19
|
JP |
|
P
|
Parsan Makina Parcalari Sanayii AS
IST:PARSN.E
|
TR |
|
Velocity Composites PLC
LSE:VEL
|
UK |
|
MegaPower Makmur Tbk PT
IDX:MPOW
|
ID |
|
Fras Le SA
BOVESPA:FRAS3
|
BR |
|
Invex Controladora SAB De CV
BMV:INVEXA
|
MX |
|
V
|
Vincenzo Zucchi SpA
MIL:ZUC
|
IT |
|
Sterling and Wilson Renewable Energy Ltd
NSE:SWSOLAR
|
IN |
Bankruptcy Probability
Hualan Biological Engineering Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hualan Biological Engineering Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Hualan Biological Engineering Inc
SZSE:002007
|
27.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hualan Biological Engineering Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hualan Biological Engineering Inc has total debt of 455.4m CNY. This includes both short-term (447m CNY) and long-term (8.4m CNY) debt.
You can find a full breakdown on its Balance Sheet.
